Pharming (PHAR) FCF Margin (2020 - 2025)
Pharming (PHAR) posted FCF Margin of 10756807.51% for Q4 2025, up 2288.82% on a QoQ basis from 491442.54% in Q4 2024, and up 1124825005.0% year-over-year from N/an in Q4 2024.
Pharming (PHAR) FCF Margin (2020 - 2025) Analysis & Trends
Pharming's FCF Margin history runs 6 years deep, the most recent figure standing at 10756807.51% for Q4 2025.
- Quarterly FCF Margin rose 1124825005.0% year-over-year to 10756807.51% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 6.75% (down 27.0% YoY) and the FY2025 annual result came in at 14.35%, up 1522.0% from the prior year.
- FCF Margin was 10756807.51% for Q4 2025 at Pharming, up from 491442.54% in the prior quarter.
- Across five years, FCF Margin topped out at 13513368.98% in Q3 2024 and bottomed at 19538177.34% in Q4 2023.
- A 5-year average of 424056.86% and a median of 3.03% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 1953817788 bps — and 2024, when it surged 1904673480 bps.
- Pharming's FCF Margin stood at 0.03% in 2021, then surged by 1708 bps to 0.54% in 2022, then plunged by 2000000000 bps to 19538177.34% in 2023, then surged by 97 bps to 491442.54% in 2024, then soared by 2289 bps to 10756807.51% in 2025.
- Business Quant data shows PHAR's FCF Margin at 10756807.51% in Q4 2025, 491442.54% in Q4 2024, and 13513368.98% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,756,807.51% |
| Dec 31, 2024 | -491,442.54% |
| Sep 30, 2024 | 13,513,368.98% |
| Dec 31, 2023 | -19,538,177.34% |
| Sep 30, 2023 | 5.51% |
| Jun 30, 2023 | -32.25% |
| Dec 31, 2022 | 0.54% |
| Sep 30, 2022 | 23.91% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | 14.30% |
| Dec 31, 2020 | 0.09% |
| Sep 30, 2020 | 32.58% |